Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells (Q40561027)

21 September 2017

title

Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells (English)

1 reference

21 September 2017

1 reference

Wasim Chowdhury

7

0 references

Martine Lamfers

object named as

Martine Lamfers

5

0 references

author name string

Markus D Sachs

1

1 reference

21 September 2017

Meera Ramamurthy

2

1 reference

21 September 2017

Henk van der Poel

3

1 reference

21 September 2017

Thomas J Wickham

4

1 reference

21 September 2017

Winald Gerritsen

6

1 reference

21 September 2017

Ying Li

8

1 reference

21 September 2017

Mark P Schoenberg

9

1 reference

21 September 2017

Ronald Rodriguez

10

1 reference

21 September 2017

publication date

1 July 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

11

1 reference

21 September 2017

issue

7

1 reference

21 September 2017

page(s)

477-486

1 reference

21 September 2017

cites work

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Management of superficial bladder cancer with intravesical chemotherapy: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Signaling antibodies complexed with adenovirus circumvent CAR and integrin interactions and improve gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Alkaline phosphatase activity in human bladder tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Characterization of insulin-like growth factor I binding sites in human bladder cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Establishment, characterisation and partial cytokine expression profile of a new human osteosarcoma cell line (CAL 72).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Epidermal growth factor receptor targeting enhances adenoviral vector based suicide gene therapy of osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Adenovirus-mediated suicide gene therapy for experimental bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Prostate cancer prevention strategies using antiproliferative or differentiating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Variability of cell surface glycoconjugates--relation to differences in cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Structure, function, and pathology of proteoglycans and glycosaminoglycans in the urinary tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700726

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.CGT.7700726

1 reference

Dimensions Publication ID

21 September 2017

1022653733

0 references

1 reference